This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kohner, E. M Search for Related Content Social Bookmarking                   What's this?

Review: Thirty-seven years with diabetic retinopathy

Department of Medicine, St Thomas Hospital, Lambeth Palace Road, London, SE1 7EH, UK, e.kohner{at}kcl.ac.uk

Diabetic retinopathy was rare 50 years ago. Since then it has become the commonest cause of visual loss in the working age population. Initially the only treatment available was pituitary ablation, and that only worked for some patients with proliferative retinopathy. In the 1970s laser treatment revolutionised the management of retinopathy. Improvements in the assessment and management of retinopathy stimulated research with controlled clinical trials. This has resulted in evidence-based recommendations for improvement in glucose and blood pressure control which has been shown to reduce the prevalence of retinopathy. Screening procedures are now available for most people with diabetes. New treatments under development, directed at the pathogenic mechanisms of retinopathy, offer hope that the laser will eventually be replaced by more effective and better tolerated treatment.

Key Words: diabetic retinopathy • pituitary ablation • photocoagulation • screening • photographic grading.

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 6, 452-456 (2002)
DOI: 10.1177/14746514020020060701


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?